CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 150 enrolled
Drug / intervention
ONBOARDbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04672655
NCT04672655N/ACompleted
CompareCT.gov

Overcoming Barriers and Obstacles to Adopting Diabetes Devices (ONBOARD) Trial

Molly Tanenbaum·interventional·Posted Dec 17, 2020·Updated Sep 5, 2025

In Brief

A clinical study evaluating ONBOARD for Type 1 Diabetes. Completed, enrolled 150 participants across 1 site.

Detailed Summary

This study is a comprehensive, multicomponent behavioral intervention package (ONBOARD; OvercomiNg Barriers \& Obstacles to Adopting Diabetes Devices). ONBOARD will provide adults with T1D the skills to maximize benefit and minimize daily interference from barriers associated with Continuous Glucose Monitoring (CGM) and increase readiness for closed loop.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes
CountriesUnited States
CollaboratorsNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedDec 17, 2020
Enrollment StartFeb 17, 2021
Primary CompletionSep 16, 2024
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 5.5 years ago

Interventions

ONBOARDbehavioral

Session 1: Overview; Wearing diabetes devices; Session 2: Managing CGM data; Session 3: CGM \& social situations; Session 4: Building trust with your CGM